Covirán has formalized this week its direct participation in Limnopharma through a convertible note. From Limnopharma we thank the Covirán Group for its trust and support for our project, which represents a boost and allows us to continue working with the aim of bringing our drugs to the market.
During the signing of this collaboration, the general director of the Covirán group, José Francisco Muñoz, highlighted that “we share your commitment to science, innovation and technology; We want to be an active part through our resources to achieve a real improvement in people’s lives. You have the talent and enormous potential. At Covirán we have the exciting challenge of helping and accompanying entrepreneurs like you who contribute value and wealth to society.”
Covirán understands that innovation is not an option for any company, and maintains its commitment to providing added value to its commercial offer, a sustainable model for citizens. A company that understands these advances as progress and a guarantee for the future, proof of this is its 61 years of life, through real involvement, specifically with those sectors especially linked to health. A sustainable model that positively impacts the spaces where it carries out its activity, generating value, innovation and improving people’s lives.
At Limnopharma we are extremely proud to have the Covirán Group as partners.